These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30697354)

  • 1. Trimetazidine and Other Metabolic Modifiers.
    Guarini G; Huqi A; Morrone D; Capozza PFG; Marzilli M
    Eur Cardiol; 2018 Dec; 13(2):104-111. PubMed ID: 30697354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update.
    Guarini G; Huqi A; Morrone D; Marzilli M
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):379-391. PubMed ID: 27497930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
    Stanley WC; Marzilli M
    Fundam Clin Pharmacol; 2003 Apr; 17(2):133-45. PubMed ID: 12667223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents.
    Jackson G
    Int J Clin Pract; 2001 May; 55(4):256-61. PubMed ID: 11406911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic therapy for the diabetic patients with ischaemic heart disease.
    Rosano GM; Vitale C; Volterrani M; Fini M
    Coron Artery Dis; 2005 Nov; 16 Suppl 1():S17-21. PubMed ID: 16340399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimetazidine for stable angina pectoris.
    Cross HR
    Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of trimetazidine: a review.
    Marzilli M
    Curr Med Res Opin; 2003; 19(7):661-72. PubMed ID: 14606990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
    Lee L; Horowitz J; Frenneaux M
    Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Angina: Where Are We?
    Balla C; Pavasini R; Ferrari R
    Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.
    Dalal JJ; Mishra S
    Indian Heart J; 2017; 69(3):393-401. PubMed ID: 28648439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced external counterpulsation--a therapeutic option for patients with chronic cardiovascular problems.
    Linnemeier G
    J Cardiovasc Manag; 2002; 13(6):20-5. PubMed ID: 12500419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimetazidine for stable angina.
    Ciapponi A; Pizarro R; Harrison J
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003614. PubMed ID: 16235330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial fatty acid oxidation inhibitors for stable angina.
    Stanley WC
    Expert Opin Investig Drugs; 2002 May; 11(5):615-29. PubMed ID: 11996644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Post Percutaneous Coronary Intervention Myocardial Ischaemia.
    Huqi A; Guarini G; Morrone D; Marzilli M
    Eur Cardiol; 2016 Dec; 11(2):85-89. PubMed ID: 30310453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers].
    Hanania G; Haïat R; Olive T; Maalouf B; Michel D; Martelet M; Godard S;
    Ann Cardiol Angeiol (Paris); 2002 Nov; 51(5):268-74. PubMed ID: 12515103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Agranulocytosis and acute coronary syndrome in apathetic hyperthyroidism].
    Ivović M; Radiojković B; Penezić Z; Stojković M; Tancić M; Vujović S; Bogdanović A; Drezgić M
    Srp Arh Celok Lek; 2003; 131(5-6):249-53. PubMed ID: 14692133
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.